Phase 1 Study of URC102 in Healthy Subjects

A Phase I, Placebo-controlled, Randomized, Double Blind, Single or Multiple Dose Study of URC102 in Healthy Male Volunteers of Korean and Caucasian to Assess Safety, Pharmacokinetics and Pharmacodynamics

To assess the safety, tolerability, PK and PD of URC102 in healthy subjects. To evaluate the food effect on PK.

Inclusion Criteria:

• Healthy male volunteers

Exclusion Criteria:

• Received other investigational drug within 12 weeks prior to the first dose of study drug